Thromboelastometry in Assessment of Sepsis Coagulopathy
Completed
- Conditions
- ThrombelastographySepsis
- Registration Number
- NCT02971111
- Lead Sponsor
- University Hospital, Motol
- Brief Summary
The purpose of this study is to analyze occurence of bleeding complications during invasive procedures in septic patients with normal tromboelastometry results despite prolonged standard coagulation tests results
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
- sepsis/septic shock
- prolonged PT-INR (international normalized ratio) ≥ 1.3
- normal ROTEM-EXTEM results.
Exclusion Criteria
- patients on antiplatelet drugs or anticoagulant therapy (heparin, vitamin K antagonists...)
- patients with cirrhosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of bleeding complications 2013 - 2016 In our group of 76 septic patients who had normal values of EXTEM despite prolonged INR/PR invasive procedures were performed without severe bleeding.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link thromboelastometry results to bleeding risk in septic patients with normal coagulation tests?
How does thromboelastometry compare to standard coagulation tests in predicting bleeding during invasive procedures in sepsis?
Which biomarkers correlate with sepsis-induced coagulopathy and thromboelastometry outcomes in clinical studies?
What adverse events are associated with thromboelastometry-guided management in septic patients with coagulopathy?
Are there combination therapies or alternative approaches to managing sepsis-related bleeding when thromboelastometry is normal?